The World Health Organization (WHO) has authorized the AstraZeneca COVID-19 vaccine for emergency use.
“AstraZeneca’s COVID-19 vaccine has been granted Emergency Use Listing (EUL) by the World Health Organization (WHO) for active immunization to prevent COVID-19 in individuals 18 years of age and older, including those over 65.”
-AstraZeneca
According to WHO, they have listed two versions of the AstraZeneca/Oxford COVID-19 vaccine for emergency use giving the green light for the said vaccines to be rolled out globally through COVAX which was produced by:
Furthermore, WHO’s Strategic Advisory Group of Experts on Immunization (SAGE), makes recommendations for vaccines’ use in populations, recommended the vaccine for all age groups 18 and above.
The WHO’s Emergency Use Listing (EUL):
According to WHO, for the EUL of the two AstraZeneca/Oxford vaccines, “WHO assessed the quality, safety and efficacy data, risk management plans and programmatic suitability, such as cold chain requirements. The process took under four weeks.”
AstraZeneca/Oxford product is:
Furthermore, more than 50 countries have granted emergency use for the AstraZeneca vaccine, and with the WHO EUL now accelerating the pathway to access in up to 145 countries through the COVAX Facility.
Looking for more news and updates? Feel free to explore our BCG website and our official Facebook page. You may also check out our official BCG YouTube channel to catch a variety of video content.
Source: WHO, AstraZeneca
This website uses cookies.